Abstract:Abstract Background Drug repurposing aims at finding new targets for already developed drugs. It becomes more relevant as the cost of discovering new drugs steadily increases. To find new potential targets for a drug, an abundance of methods and existing biomedical knowledge from different domains can be leveraged. Recently, knowledge graphs have emerged in the biomedical domain that integrate information about genes, drugs, diseases and other biological domains. Knowledge graphs can be used to predict new connections between compounds and diseases, leveraging the interconnected biomedical data around them. While real world use cases such as drug repurposing are only interested in one specific relation type, widely used knowledge graph embedding models simultaneously optimize over all relation types in the graph. This can lead the models to underfit the data that is most relevant for the desired relation type. For example, if we want to learn embeddings to predict links between compounds and diseases but almost the entirety of relations in the graph is incident to other pairs of entity types, then the resulting embeddings are likely not optimised to predict links between compounds and diseases. We propose a method that leverages domain knowledge in the form of metapaths and use them to filter two biomedical knowledge graphs (Hetionet and DRKG) for the purpose of improving performance on the prediction task of drug repurposing while simultaneously increasing computational efficiency. Results We find that our method reduces the number of entities by 60% on Hetionet and 26% on DRKG, while leading to an improvement in prediction performance of up to 40.8% on Hetionet and 14.2% on DRKG, with an average improvement of 20.6% on Hetionet and 8.9% on DRKG. Additionally, prioritization of antiviral compounds for SARS CoV-2 improves after task-driven filtering is applied. Conclusion Knowledge graphs contain facts that are counter productive for specific tasks, in our case drug repurposing. We also demonstrate that these facts can be removed, resulting in an improved performance in that task and a more efficient learning process.

Understanding the Performance of Knowledge Graph Embeddings in Drug Discovery

Ensembles of knowledge graph embedding models improve predictions for drug discovery

A Review of Biomedical Datasets Relating to Drug Discovery: A Knowledge Graph Perspective

Drug target discovery using knowledge graph embeddings

KG-Predict: A knowledge graph computational framework for drug repurposing

Biological Insights Knowledge Graph: an integrated knowledge graph to support drug development

MegaKG: Toward an explainable knowledge graph for early drug development

Knowledge Graph Embeddings in the Biomedical Domain: Are They Useful? A Look at Link Prediction, Rule Learning, and Downstream Polypharmacy Tasks

PharmKG: a dedicated knowledge graph benchmark for bomedical data mining

MKGE: Knowledge Graph Embedding with Molecular Structure Information.

Knowledge-augmented Graph Machine Learning for Drug Discovery: A Survey

Natural Language Processing for Drug Discovery Knowledge Graphs: promises and pitfalls

Knowledge Graphs for drug repurposing: a review of databases and methods

Task-driven knowledge graph filtering improves prioritizing drugs for repurposing

KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description

Toward Better Drug Discovery with Knowledge Graph

KGML-xDTD: A Knowledge Graph-based Machine Learning Framework for Drug Treatment Prediction and Mechanism Description

Knowledge Graph Convolutional Network with Heuristic Search for Drug Repositioning

Predicting Drug-Drug Interactions Using Knowledge Graphs

RDKG-115: Assisting drug repurposing and discovery for rare diseases by trimodal knowledge graph embedding

Evolution-strengthened Knowledge Graph Enables Predicting the Targetability and Druggability of Genes.